Lee Kevin (CIK 1776938) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell BCYC (5,905 shares), Sell BCYC (1,737 shares), Sell BCYC (5,967 shares), Sell BCYC (1,716 shares), Buy BCYC (165,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 5,905 | $25,214 |
| 2026-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 1,737 | $7,486 |
| 2026-04-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 5,967 | $29,298 |
| 2026-04-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 1,716 | $8,666 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Buy | 165,000 | $0 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 10,325 | $70,210 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 10,989 | $70,989 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 2,263 | $19,009 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 3,231 | $27,173 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 2,268 | $16,080 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 3,193 | $23,756 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 2,237 | $17,941 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF EXECUTIVE OFFICER | Sell | 3,432 | $25,671 |
Source: SEC Form 4 filings · as of 2026-07-07